Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Indivior PLC - Ordinary Shares (NQ:INDV)

31.24 +1.87 (+6.37%)
Streaming Delayed Price Updated: 3:16 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Indivior PLC - Ordinary Shares

< Previous 1 2 3 Next >
Here's Why Indivior Stock Soared 15% Today
This company is accelerating sales growth in its key prescription medication. 
Via The Motley Fool
Earnings Scheduled For October 30, 2025
 
Via Benzinga
INDIVIOR PLC (NASDAQ:INDV) Shows Top Technical and Setup Ratings for Potential Breakout
INDIVIOR (INDV) shows strong technicals with a perfect 10 rating and a 9 setup score, signaling a potential breakout above $25.20 resistance. 
Via Chartmill
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
Indivior (INDV) Q2 EPS Jumps 104%
Via The Motley Fool
Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Earnings Scheduled For April 24, 2025
 
Via Benzinga
Indivior (INDV) Q1 2025 Earnings Call
Via The Motley Fool
A Look at Indivior's Upcoming Earnings Report
 
Via Benzinga
Indivior PLC: Is This Deeply Undervalued Stock A Hidden Gem?
With a strong position in a niche yet vital therapeutic area, Indivior PLC benefits from durable brand equity, a specialized distribution network, and a long runway for product innovation. 
Via Talk Markets
Topics Stocks / Equities
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat
Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade. 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Earnings Scheduled For February 20, 2025
 
Via Benzinga
Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
 
Via Benzinga
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
Indivior cuts FY24 net revenue outlook due to competition and funding delays, causing a drop in share price. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Top 3 Health Care Stocks That May Explode This Month
 
Via Benzinga
Smith & Wesson Brands Reports Downbeat Results, Joins Planet Labs PBC, Broadcom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
 
Via Benzinga
Topics Cannabis
Health And Human Services Dept Orders OPVEE Nasal Spray For Emergency Fentanyl Overdose Response
 
Via Benzinga
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatment. Addex could receive up to $330 million plus royalties under the... 
Via Benzinga
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
INDV Stock Earnings: Indivior Beats EPS, Beats Revenue for Q2 2024
INDV stock results show that Indivior beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.